Search
for
Sort by
Research 331–360 of 1000+
- The Mechanisms and Management of Age-Related Oxidative Stress in Male Hypogonadism Associated with Non-communicable Chronic Disease
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Contributions of peroxisome proliferator-activated receptor β/δ to skin health and disease
- Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time
- The Effect of EGR1 on the Proliferation of Dermal Papilla Cells
- Targeted radionuclide therapy for head and neck squamous cell carcinoma: a review
- A Multifaceted View on Ageing of the Hair and Scalp
- Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome
- The Potential Reversible Transition between Stem Cells and Transient-Amplifying Cells: The Limbal Epithelial Stem Cell Perspective
- Clinical Applications of Extracellular Vesicles: Promises and Pitfalls
- Mineral Deficiencies: A Root Cause for Reduced Longevity in Mammals
- Hair Growth Regulation by Fibroblast Growth Factor 12 (FGF12)
- Hormonal and Genetic Etiology of Male Androgenetic Alopecia
- Peptide-Based PROTACs: Transitioning from Static Paradigm to a Dynamic Landscape within Targeted Protein Degradation
- A young male with kidney damage from genetic mitochondrial disease: case report and literature review
- LB1011 Oncogenic ras mutation induces spatiotemporally specific tissue deformation through converting fluctuated into sustained ERK activation
- Tumor suppressor identity can contribute to heterogeneity of phenotype in hair follicle stem cell‐induced squamous cell carcinoma
- Inducible Cutaneous Inflammation Reveals a Protumorigenic Role for Keratinocyte CXCR2 in Skin Carcinogenesis
- Polyamines and hair: a couple in search of perfection
- 696 MEK and BRAF inhibitors augment the production and accumulation of sebum in hamster sebocytes
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Hair growth induction by the tellurium immunomodulator AS101: association with delayed terminal differentiation of follicular keratinocytes and ras‐dependent up‐regulation of KGF expression
- Hair follicle regeneration suppresses Ras-driven oncogenic growth
- Studying the correlation of renin-angiotensin-system (RAS) components and insulin resistance in polycystic ovary syndrome (PCOs)
- Comparison of hair manifestations in cardio‐facio‐cutaneous and Costello syndromes highlights the influence of the RAS pathway on hair growth
- Injury suppresses Ras cell competitive advantage through enhanced wild-type cell proliferation
- Isoalantolactone (ISA) Stimulates Hair Cell Growth Through Activation of the WNT/β-catenin and Ras/MAPK Pathways
- QuantAnts machines discover biomarkers for RAS signaling activation and design sgRNAs for CRISPR to target complex CD9, CD34, and CD74.
- The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted